Article
Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.
Disease models & mechanisms - 1 May 2017
Lahut Suna, Gispert Suzana, Ömür Özgür, Depboylu Candan, Seidel Kay, Domínguez-Bautista Jorge Antolio, Brehm Nadine, Tireli Hülya, Hackmann Karl, Pirkevi Caroline, Leube Barbara, Ries Vincent, Reim Kerstin, Brose Nils, den Dunnen Wilfred F, Johnson Madrid, Wolf Zsuzsanna, Schindewolf Marc, Schrempf Wiebke, Reetz Kathrin, Young Peter, Vadasz David, Frangakis Achilleas S, Schröck Evelin, Steinmetz Helmuth, Jendrach Marina, Rüb Udo, Başak Ayşe Nazlı, Oertel Wolfgang, Auburger Georg
Abstract excerpt
Parkinson's disease (PD) is a frequent neurodegenerative process in old age. Accumulation and aggregation of the lipid-binding SNARE complex component α-synuclein (SNCA) underlies this vulnerability and defines stages of disease progression. Determinants of SNCA levels and mechanisms of SNCA neurotoxicity have been intensely investigated. In view of the physiological roles of SNCA in blood to modulate vesicle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
